Search clinical trials for: HR HER2-
Total 26383 results
-
Novartis PharmaceuticalsActive, not recruiting
-
Nuvation Bio Inc.WithdrawnBreast Cancer | Advanced Breast Cancer | Metastatic Breast Cancer | Breast Carcinoma | Cancer of Breast | Malignant Tumor of Breast | Breast Tumor | Cancer of the BreastUnited States
-
iOMEDICO AGPfizerCompletedBreast Cancer | Hormone Receptor Positive Tumor | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastGermany
-
West German Study GroupAgendiaRecruitingFemale Breast CancerGermany
-
UNICANCERNovartis; Breast Cancer Research FoundationRecruiting
-
Georgetown UniversityPfizerActive, not recruitingMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of Breast | Hormone Receptor Positive Breast CancerUnited States
-
University of Wisconsin, MadisonNational Cancer Institute (NCI)Recruiting
-
Accutar Biotechnology IncRecruiting
-
AstraZenecaAustrian Breast and Colorectal Cancer Study Group (ABCSG)RecruitingBreast Cancer, Early Breast CancerUnited States, Spain, Italy, Korea, Republic of, Belgium, Canada, Poland, Portugal, United Kingdom, France, China, Germany, Japan, Mexico, Thailand, Hungary, Australia, Austria, Brazil, Colombia, Taiwan, Malaysia, Philippines, Romania, ... and more
-
Novartis PharmaceuticalsCompletedHormone Receptor Positive Breast CancerUnited States, Argentina, Thailand, Japan, France, Korea, Republic of, Spain, Turkey, Hungary, United Kingdom, Portugal, Brazil, Netherlands
-
Bristol-Myers SquibbCompletedCancer | Breast CancerBelgium, United States, Spain, France, Germany, Australia, Canada, Puerto Rico
-
Sichuan Provincial People's HospitalUnknownHER2-negative Breast CancerChina
-
Gary SchwartzWithdrawn
-
Tolmar Inc.RecruitingBreast CancerUnited States, Mexico, Brazil, Canada, Puerto Rico, Argentina
-
Novartis PharmaceuticalsActive, not recruiting
-
Arvinas Inc.PfizerActive, not recruitingBreast CancerUnited States, Spain, Germany, Georgia
-
Novartis PharmaceuticalsSuspendedEarly Breast CancerAustralia
-
Tolmar Inc.Enrolling by invitationBreast CancerUnited States, Puerto Rico
-
Novartis PharmaceuticalsTerminated
-
G1 Therapeutics, Inc.Active, not recruitingBreast Cancer | Breast Neoplasm | Carcinoma, Ductal, BreastUnited Kingdom, Bulgaria, Georgia, Moldova, Republic of
-
Novartis PharmaceuticalsTerminatedMetastatic Breast CancerUnited States, Germany, Belgium, Canada, France, Italy, Spain, United Kingdom, Austria, Argentina, Sweden, Hungary, Korea, Republic of, Lebanon, Bulgaria, Greece, Thailand, Netherlands, Colombia, Norway, Finland, Poland
-
Peking University First HospitalNot yet recruiting
-
RemeGen Co., Ltd.Completed
-
Universitair Ziekenhuis BrusselKom Op Tegen Kanker; Agentschap voor Innovatie door Wetenschap en Technologie...RecruitingGastric Cancer | Colorectal Cancer | Prostate Cancer | Non Small Cell Lung Cancer | Cholangiocarcinoma | Endometrial Cancer | Urothelial Carcinoma | Biliary Tract Cancer | Locally Advanced Breast Cancer | Cancer of Pancreas | Uterine Cancer | Salivary Gland Cancer | Metastatic Breast Carcinoma | Solid Tumor With Intermediate...Belgium
-
AstraZenecaRecruitingBreast Cancer, Early Breast CancerUnited States, Canada, United Kingdom, China, Argentina, Australia, Hungary, Netherlands, Korea, Republic of, France, Germany, Italy, Belgium, Bulgaria, India, Mexico, Spain, Vietnam, Colombia, Japan, Peru, Brazil, Malaysia, Taiwan, Tha... and more
-
Institute of Cancer Research, United KingdomRecruitingBreast Cancer FemaleUnited Kingdom
-
Accutar Biotechnology IncTerminatedBreast CancerUnited States
-
Arvinas Estrogen Receptor, Inc.PfizerActive, not recruitingBreast CancerUnited States, Spain
-
G1 Therapeutics, Inc.CompletedBreast Cancer | Advanced Breast Cancer | Breast Neoplasm | Metastatic Breast Cancer | Stage IV Breast Cancer | Carcinoma, Ductal, Breast | Breast Cancer FemaleUnited States, Belgium, Bulgaria, Georgia, Netherlands, Moldova, Republic of, Ukraine
-
Dartmouth-Hitchcock Medical CenterCompleted
-
Consorzio OncotechClinical Research Technology S.r.l.UnknownMetastatic Breast Cancer | Human Epidermal Growth Factor 2 Negative Carcinoma of BreastItaly
-
Baylor College of MedicineThe Methodist Hospital Research Institute; Center for Cell and Gene Therapy...CompletedHER2 Positive MalignanciesUnited States
-
First Affiliated Hospital of Zhejiang UniversityNot yet recruiting
-
Anne Arundel Health System Research InstituteGenentech, Inc.Unknown
-
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.Not yet recruiting
-
Zhi YangWithdrawnGlioma | Breast Cancer | Gastric Cancer | Colorectal Cancer | Pancreatic Cancer | Ovarian Cancer | Lung CancerChina
-
Peking Union Medical College HospitalCompletedBreast CancerChina
-
First People's Hospital of HangzhouMacera therapeuticsNot yet recruiting
-
Karolinska University HospitalRecruitingBreast Cancer | Esophageal Neoplasms | HER2-positive Gastric Cancer | Gastric Neoplasms MalignantSweden
-
PrecirixCompleted
-
Sichuan UniversityRecruitingPleural Effusion, Malignant | Peritoneal Carcinoma MetastaticChina
-
su haichuanNot yet recruiting
-
Xijing HospitalNot yet recruitingHER2-positive Breast Cancer and Gastric Cancer
-
Peking University Cancer Hospital & InstituteRecruitingHER2 Positive or Suspicious Positive TumorsChina
-
Alphamab (Australia) Co Pty Ltd.RecruitingAdvanced Solid Tumors | Metastatic Solid TumorsAustralia
-
Bristol-Myers SquibbCompletedSolid Tumors That Overexpress HER2 (HER2 Positive)United States, Canada
-
Beijing 302 HospitalRecruiting
-
Dorte NielsenTerminated
-
Pieris Pharmaceuticals, Inc.CompletedHER2-positive Breast Cancer | HER2-positive Gastric Cancer | HER2-positive Bladder Cancer | HER2-positive Solid TumorUnited States
-
University of Maryland, BaltimoreWithdrawnBreast Cancer With Brain MetastasisUnited States